Regulon

Regulon: R-1813

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
152.7964112Pr-0Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
841 ENSG00000064012 CASP8 Q14790
966 ENSG00000085063 CD59 P13987
29957 ENSG00000085491 SLC25A24 Q6NUK1
7076 ENSG00000102265 TIMP1 Q6FGX5
8717 ENSG00000102871 TRADD Q15628
5216 ENSG00000108518 PFN1 P07737
4179 ENSG00000117335 CD46 P15529
7045 ENSG00000120708 TGFBI Q15582
6237 ENSG00000126458 RRAS P10301
813 ENSG00000128595 CALU O43852
3597 ENSG00000131724 IL13RA1 P78552
831 ENSG00000153113 CAST P20810
5937 ENSG00000153250 RBMS1 P29558
7106 ENSG00000214063 TSPAN4 O14817
123803 ENSG00000275779 NTAN1 H3BNJ5

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
CINTREDEKIN BESUDOTOXIL4RProteinBINDING AGENTInterleukin 13 receptor binding agent33
NIVOCASANCASP1Small moleculeINHIBITORCaspase-9 inhibitor20
EMRICASANCASP4Small moleculeINHIBITORCaspase inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1813

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-27636ANKRD36down-regulatesSPDEFrepressesR-1813173Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

CINTREDEKIN BESUDOTOX, NIVOCASAN, EMRICASAN

CMF-28985ZFC3H1down-regulatesSPDEFrepressesR-1813172Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

CINTREDEKIN BESUDOTOX, NIVOCASAN, EMRICASAN